Arformoterol Tartrate has 12 known drug interactions based on U.S. FDA drug labeling data. 5 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Drugs That Prolong Qtc Interval, Drugs That Prolong The Qt Interval, Mao Inhibitors. Patients taking Arformoterol Tartrate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 12
- Major
- 5
- Moderate
- 7
Major (5)
- Arformoterol Tartrate + Drugs That Prolong Qtc Interval— Drugs that prolong QTc interval may potentiate cardiovascular effects. Use with extreme caution.
- Arformoterol Tartrate + Drugs That Prolong The Qt Interval— QTc prolonging drugs may potentiate cardiovascular effects of arformoterol. Use with extreme caution.
- Arformoterol Tartrate + Mao Inhibitors— May potentiate cardiovascular effects of arformoterol. Use with extreme caution.
- Arformoterol Tartrate + Monoamine Oxidase Inhibitors (Maois)— May potentiate cardiovascular effects of arformoterol. Should be administered with extreme caution.
- Arformoterol Tartrate + Nonselective Beta-Adrenergic Antagonists— May decrease effectiveness and block bronchodilatory effects of arformoterol. Use with caution and only when medically n…
Moderate (7)
- Arformoterol Tartrate + Aminophylline— Xanthine derivative may potentiate hypokalemia. Concomitant use may increase heart rate and systolic blood pressure. Use…
- Arformoterol Tartrate + Andthiazide— Non-potassium sparing diuretics may cause ECG changes and hypokalemia that can be worsened by beta-agonists. Use with ca…
- Arformoterol Tartrate + Diuretics— May potentiate hypokalemia or ECG changes. Use with caution.
- Arformoterol Tartrate + Loop Diuretics— Non-potassium sparing diuretics may cause ECG changes and hypokalemia that can be worsened by beta-agonists. Use with ca…
- Arformoterol Tartrate + Potassium Supplements— Loop or thiazide diuretics can worsen ECG changes and hypokalemia. Caution advised in co-administration.
- Arformoterol Tartrate + Theophylline— Xanthine derivative may potentiate hypokalemia. Concomitant use associated with increased heart rate (2-3 bpm) and systo…
- Arformoterol Tartrate + Topical Steroids— May potentiate hypokalemia or ECG changes. Use with caution.